Evidence map›Paper›PMID 37277838›Full record

ArticleJournal of biomedical science2023

Apo- and holo-transferrin differentially interact with hephaestin and ferroportin in a novel mechanism of cellular iron release regulation.

Stephanie L Baringer, Kondaiah Palsa, Vladimir S Spiegelman, Ian A Simpson, James R Connor

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Ferroptosis: a new target for depression prevention and treatment.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. The role of ferroptosis-related non-coding RNA in liver fibrosis.Frontiers in cell and developmental biology · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stephanie L BaringerDepartment of Neurosurgery, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA.
Kondaiah PalsaDepartment of Neurosurgery, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA.
Vladimir S SpiegelmanDepartment of Pediatrics, Penn State College of Medicine, Hershey, PA, USA.
Ian A SimpsonDepartment of Neural and Behavioral Sciences, Penn State College of Medicine, Hershey, PA, USA.
James R ConnorDepartment of Neurosurgery, Penn State College of Medicine, 500 University Drive, Hershey, PA, 17033, USA. jconnor@pennstatehealth.psu.edu.
Pennsylvania State University · USPenn State Milton S. Hershey Medical Center · US

Funding

NRSA Training CoreTL1TR002016 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI THOMAS, GAIL D. · 2016 to 2025
$3.4M
Mechanisms and Regulation of Brain Iron UptakeR01NS113912 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CONNOR, JAMES ROBERT · 2020 to 2024
$2.6M
National Institute of Health R01NS113912-01National Institute of Health TL1TR002016NCATS NIH HHS TL1 TR002016NINDS NIH HHS R01 NS113912
6 · The paper itself

Abstract

backgroundApo- (iron free) and holo- (iron bound) transferrin (Tf) participate in precise regulation of brain iron uptake at endothelial cells of the blood-brain barrier. Apo-Tf indicates an iron-deficient environment and stimulates iron release, while holo-Tf indicates an iron sufficient environment and suppresses additional iron release. Free iron is exported through ferroportin, with hephaestin as an aid to the process. Until now, the molecular mechanisms of apo- and holo-Tf influence on iron release was largely unknown.

methodsHere we use a variety of cell culture techniques, including co-immunoprecipitation and proximity ligation assay, in iPSC-derived endothelial cells and HEK 293 cells to investigate the mechanism by which apo- and holo-Tf influence cellular iron release. Given the established role of hepcidin in regulating cellular iron release, we further explored the relationship of hepcidin to transferrin in this model.

resultsWe demonstrate that holo-Tf induces the internalization of ferroportin through the established ferroportin degradation pathway. Furthermore, holo-Tf directly interacts with ferroportin, whereas apo-Tf directly interacts with hephaestin. Only pathophysiological levels of hepcidin disrupt the interaction between holo-Tf and ferroportin, but similar hepcidin levels are unable to interfere with the interaction between apo-Tf and hephaestin. The disruption of the holo-Tf and ferroportin interaction by hepcidin is due to hepcidin's ability to more rapidly internalize ferroportin compared to holo-Tf.

conclusionsThese novel findings provide a molecular mechanism for apo- and holo-Tf regulation of iron release from endothelial cells. They further demonstrate how hepcidin impacts these protein-protein interactions, and offer a model for how holo-Tf and hepcidin cooperate to suppress iron release. These results expand on our previous reports on mechanisms mediating regulation of brain iron uptake to provide a more thorough understanding of the regulatory mechanisms mediating cellular iron release in general.

Indexed as

HepcidinsTransferrinEndothelial CellsFerroportinHEK293 CellsHumansFerroportinHepcidinsTransferrinBlood–brain barrierFerroportinHepcidinHephaestinIronTransferrin

Identifiers

PMID37277838
PMCPMC10243088
OpenAlexW4379508118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.